Plunkett Research Online: Virbac SA

VIRBAC SA (VRBCF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Virbac SA is a major drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America. Most of the company's sales are generated from its Companion Animals segment, followed by its Food Producing A.....



Virbac SA
Ticker: VRBCF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 492087100
Fax: 33 492087165
Address: 2065m LID
1 ere avenue
Carros, 06516 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Veterinary Pharmaceuticals
Product Development
Product Manufacturing
Contacts Description
Marie-Helene Dick-MadelpuechChairman of the Board/Director
Solene MadelpuechDirector
See More
Virbac SA is a major drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America. Most of the company's sales are generated from its Companion Animals segment, followed by its Food Producing A.....See More See More

Auditor: Novances-David & Associes
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Fr3sh Technology
Cyclavance
Deltanil
Effitix
Neoprinil
Pronefra
Milpro
CET OraStrip
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: